349 related articles for article (PubMed ID: 35530147)
1. Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives.
Jin Q; Wu J; Wu Y; Li H; Finel M; Wang D; Ge G
Acta Pharm Sin B; 2022 Mar; 12(3):1068-1099. PubMed ID: 35530147
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
Rushmore TH; Kong AN
Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
[TBL] [Abstract][Full Text] [Related]
3. INTEDE: interactome of drug-metabolizing enzymes.
Yin J; Li F; Zhou Y; Mou M; Lu Y; Chen K; Xue J; Luo Y; Fu J; He X; Gao J; Zeng S; Yu L; Zhu F
Nucleic Acids Res; 2021 Jan; 49(D1):D1233-D1243. PubMed ID: 33045737
[TBL] [Abstract][Full Text] [Related]
4. Regulation of drug-metabolizing enzymes by local and systemic liver injuries.
Guo Y; Hu B; Xie Y; Billiar TR; Sperry JL; Huang M; Xie W
Expert Opin Drug Metab Toxicol; 2016; 12(3):245-51. PubMed ID: 26751558
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review.
Raju B; Choudhary S; Narendra G; Verma H; Silakari O
Drug Metab Rev; 2021 Feb; 53(1):45-75. PubMed ID: 33535824
[TBL] [Abstract][Full Text] [Related]
6. Induction of phase I, II and III drug metabolism/transport by xenobiotics.
Xu C; Li CY; Kong AN
Arch Pharm Res; 2005 Mar; 28(3):249-68. PubMed ID: 15832810
[TBL] [Abstract][Full Text] [Related]
7. Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species.
van Groen BD; Nicolaï J; Kuik AC; Van Cruchten S; van Peer E; Smits A; Schmidt S; de Wildt SN; Allegaert K; De Schaepdrijver L; Annaert P; Badée J
Pharmacol Rev; 2021 Apr; 73(2):597-678. PubMed ID: 33608409
[TBL] [Abstract][Full Text] [Related]
8. The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology.
Nigam SK; Bush KT; Bhatnagar V; Poloyac SM; Momper JD
Clin Pharmacol Ther; 2020 Jul; 108(1):40-53. PubMed ID: 32119114
[TBL] [Abstract][Full Text] [Related]
9. Schisandra chinensis regulates drug metabolizing enzymes and drug transporters via activation of Nrf2-mediated signaling pathway.
He JL; Zhou ZW; Yin JJ; He CQ; Zhou SF; Yu Y
Drug Des Devel Ther; 2015; 9():127-46. PubMed ID: 25552902
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of hepatic enzyme activities of drug metabolizing enzymes-phenotyping and genotyping].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):63-76. PubMed ID: 10859937
[TBL] [Abstract][Full Text] [Related]
11. Effects of liver diseases on drug-metabolizing enzymes: implications for drug fate alterations and nano-therapeutic openings.
Lu L; Shi J; Li Q; Peng X; Dong L; Li Y; Dai P; Wang Y; Guo E; Zhou F; Liu Z
Curr Med Chem; 2014; 21(22):2522-41. PubMed ID: 24358976
[TBL] [Abstract][Full Text] [Related]
12. Advances in drug metabolism and pharmacogenetics research in Australia.
Mackenzie PI; Somogyi AA; Miners JO
Pharmacol Res; 2017 Feb; 116():7-19. PubMed ID: 27956261
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of pharmacokinetic studies on herbal drug Fuzi: Implications for Fuzi as personalized medicine.
Wu JJ; Guo ZZ; Zhu YF; Huang ZJ; Gong X; Li YH; Son WJ; Li XY; Lou YM; Zhu LJ; Lu LL; Liu ZQ; Liu L
Phytomedicine; 2018 May; 44():187-203. PubMed ID: 29526584
[TBL] [Abstract][Full Text] [Related]
14. Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it.
Verma H; Singh Bahia M; Choudhary S; Kumar Singh P; Silakari O
Drug Metab Rev; 2019 May; 51(2):196-223. PubMed ID: 31203662
[TBL] [Abstract][Full Text] [Related]
15. Induction of xenobiotic receptors, transporters, and drug metabolizing enzymes by oxycodone.
Hassan HE; Myers AL; Lee IJ; Mason CW; Wang D; Sinz MW; Wang H; Eddington ND
Drug Metab Dispos; 2013 May; 41(5):1060-9. PubMed ID: 23439660
[TBL] [Abstract][Full Text] [Related]
16. High-throughput metabolism-induced toxicity assays demonstrated on a 384-pillar plate.
Yu KN; Kang SY; Hong S; Lee MY
Arch Toxicol; 2018 Aug; 92(8):2501-2516. PubMed ID: 29974144
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Regulation of Differentially Expressed Drug-Metabolizing Enzymes in Cancer.
Wang J; Yu L; Jiang H; Zheng X; Zeng S
Drug Metab Dispos; 2020 Sep; 48(9):759-768. PubMed ID: 32601104
[TBL] [Abstract][Full Text] [Related]
18. Effects of renal diseases on the regulation and expression of renal and hepatic drug-metabolizing enzymes: a review.
Korashy HM; Elbekai RH; El-Kadi AO
Xenobiotica; 2004 Jan; 34(1):1-29. PubMed ID: 14742134
[TBL] [Abstract][Full Text] [Related]
19. The pharmacogenetics of drug metabolizing enzymes in the Lebanese population.
Ossaily S; Zgheib NK
Drug Metabol Drug Interact; 2014; 29(2):81-90. PubMed ID: 24413215
[TBL] [Abstract][Full Text] [Related]
20. High-Throughput Assessment of Metabolism-Induced Toxicity of Compounds on a 384-Pillar Plate.
Kang SY; Yu KN; Joshi P; Lee MY
Methods Mol Biol; 2020; 2089():191-207. PubMed ID: 31773656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
